Transplantation of autologous mitochondria into ischemic tissue may mitigate injury caused by ischemia and reperfusion. Using murine stroke models of middle cerebral artery occlusion, we demonstrate that it is feasible to deliver viable mitochondria to ischemic brain parenchyma via an intra-arterial route of administration. We also show the beneficial supplemental effects of concurrent focused ultrasound activation of microbubbles, which serves to open the blood-brain barrier without hemorrhagic complications. Following delivery, mitochondria distribute through the stroked hemisphere and integrate into neural and glial cells in the brain parenchyma. Consistent with functional integration in the ischemic tissue, the transplanted mitochondria elevate concentration of adenosine triphosphate in the stroked hemisphere, reduce infarct volume and increase neuronal viability. Our results have implications for the development of interventional strategies after ischemic stroke and suggest a novel potential modality of therapy after mechanical thrombectomy.
Norat, Pedro and Sokolowski, Jennifer D. and Gorick, Catherine M. and Soldozy, Sauson and Chae, Youngrok and Yagmurlu, Kaan and Sharifi, Khadijeh A. and Walker, Melanie and Levitt, Michael R. and Klibanov, Alexander L. and Yan, Zhen and Price, Richard J. and Tvrdik, Petr and Kalani, M. Yashar S., Intra-Arterial Transplantation of Mitochondria after Ischemic Stroke Reduces Cerebral Infarction. Available at SSRN: https://ssrn.com/abstract=3535869 or http://dx.doi.org/10.2139/ssrn.3535869
This version of the paper has not been formally peer reviewed.
Subscribe to this fee journal for more curated articles on this topic
FOLLOWERS
16
PAPERS
912
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.